Software - Application
Compare Stocks
5 / 10Stock Comparison
ADEA vs IPGP vs PTEN vs ACTG vs VRNS
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Oil & Gas Drilling
Specialty Business Services
Software - Infrastructure
ADEA vs IPGP vs PTEN vs ACTG vs VRNS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Semiconductors | Oil & Gas Drilling | Specialty Business Services | Software - Infrastructure |
| Market Cap | $3.04B | $4.31B | $4.33B | $454M | $3.37B |
| Revenue (TTM) | $460M | $1.04B | $4.66B | $215M | $660M |
| Net Income (TTM) | $122M | $29M | $-119M | $-18M | $-137M |
| Gross Margin | 67.8% | 37.6% | 8.8% | 104.9% | 78.1% |
| Operating Margin | 46.3% | 0.3% | -1.6% | -18.7% | -21.9% |
| Forward P/E | 19.1x | 62.6x | — | 21.4x | 242.2x |
| Total Debt | $436M | $0.00 | $1.28B | $100M | $572M |
| Cash & Equiv. | $73M | $404M | $421M | $307M | $202M |
ADEA vs IPGP vs PTEN vs ACTG vs VRNS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Adeia Inc. (ADEA) | 100 | 753.3 | +653.3% |
| IPG Photonics Corpo… (IPGP) | 100 | 65.4 | -34.6% |
| Patterson-UTI Energ… (PTEN) | 100 | 309.2 | +209.2% |
| Acacia Research Cor… (ACTG) | 100 | 181.7 | +81.7% |
| Varonis Systems, In… (VRNS) | 100 | 102.0 | +2.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ADEA vs IPGP vs PTEN vs ACTG vs VRNS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ADEA carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 298.3% 10Y total return vs VRNS's 317.5%
- Lower P/E (19.1x vs 242.2x)
- 26.5% margin vs VRNS's -20.7%
- 11.6% ROA vs VRNS's -8.2%, ROIC 19.0% vs -11.0%
IPGP lags the leaders in this set but could rank higher in a more targeted comparison.
PTEN is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.59, yield 2.8%
- Beta 0.59, yield 2.8%, current ratio 1.64x
- Beta 0.59 vs ADEA's 1.95, lower leverage
- 2.8% yield, 1-year raise streak, vs ADEA's 0.7%, (3 stocks pay no dividend)
ACTG ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 133.2%, EPS growth 161.1%, 3Y rev CAGR 68.9%
- Lower volatility, beta 0.76, Low D/E 17.2%, current ratio 9.18x
- 133.2% revenue growth vs PTEN's -10.3%
Among these 5 stocks, VRNS doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 133.2% revenue growth vs PTEN's -10.3% | |
| Value | Lower P/E (19.1x vs 242.2x) | |
| Quality / Margins | 26.5% margin vs VRNS's -20.7% | |
| Stability / Safety | Beta 0.59 vs ADEA's 1.95, lower leverage | |
| Dividends | 2.8% yield, 1-year raise streak, vs ADEA's 0.7%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +111.0% vs VRNS's -36.7% | |
| Efficiency (ROA) | 11.6% ROA vs VRNS's -8.2%, ROIC 19.0% vs -11.0% |
ADEA vs IPGP vs PTEN vs ACTG vs VRNS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ADEA vs IPGP vs PTEN vs ACTG vs VRNS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ADEA leads in 3 of 6 categories
ACTG leads 1 • PTEN leads 1 • IPGP leads 0 • VRNS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ADEA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PTEN is the larger business by revenue, generating $4.7B annually — 21.7x ACTG's $215M. ADEA is the more profitable business, keeping 26.5% of every revenue dollar as net income compared to VRNS's -20.7%. On growth, VRNS holds the edge at +26.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $460M | $1.0B | $4.7B | $215M | $660M |
| EBITDAEarnings before interest/tax | $274M | $55M | $851M | -$8M | -$135M |
| Net IncomeAfter-tax profit | $122M | $29M | -$119M | -$18M | -$137M |
| Free Cash FlowCash after capex | $156M | $8M | $273M | $52M | $120M |
| Gross MarginGross profit ÷ Revenue | +67.8% | +37.6% | +8.8% | +104.9% | +78.1% |
| Operating MarginEBIT ÷ Revenue | +46.3% | +0.3% | -1.6% | -18.7% | -21.9% |
| Net MarginNet income ÷ Revenue | +26.5% | +2.8% | -2.6% | -8.5% | -20.7% |
| FCF MarginFCF ÷ Revenue | +33.8% | +0.8% | +5.9% | +24.4% | +18.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +19.5% | +16.6% | -12.7% | -56.4% | +26.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | -54.4% | — | -164.0% | 0.0% |
Valuation Metrics
ACTG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 21.4x trailing earnings, ACTG trades at a 85% valuation discount to IPGP's 139.2x P/E. On an enterprise value basis, ACTG's 5.0x EV/EBITDA is more attractive than IPGP's 48.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.0B | $4.3B | $4.3B | $454M | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $3.9B | $5.2B | $248M | $3.7B |
| Trailing P/EPrice ÷ TTM EPS | 27.70x | 139.22x | -47.54x | 21.39x | -25.38x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.09x | 62.62x | — | — | 242.23x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 12.70x | 48.90x | 5.67x | 4.98x | — |
| Price / SalesMarket cap ÷ Revenue | 6.85x | 4.30x | 0.90x | 1.59x | 5.40x |
| Price / BookPrice ÷ Book value/share | 6.45x | 2.04x | 1.36x | 0.78x | 6.19x |
| Price / FCFMarket cap ÷ FCF | 20.33x | — | 11.64x | 7.75x | 24.99x |
Profitability & Efficiency
ADEA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ADEA delivers a 27.7% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-27 for VRNS. ACTG carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRNS's 0.96x. On the Piotroski fundamental quality scale (0–9), ADEA scores 9/9 vs VRNS's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +27.7% | +1.4% | -3.7% | -3.2% | -27.4% |
| ROA (TTM)Return on assets | +11.6% | +1.2% | -2.2% | -2.4% | -8.2% |
| ROICReturn on invested capital | +19.0% | +0.6% | -0.4% | +1.2% | -11.0% |
| ROCEReturn on capital employed | +21.1% | +0.6% | -0.5% | +0.9% | -14.0% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 6 | 5 | 9 | 5 |
| Debt / EquityFinancial leverage | 0.91x | — | 0.40x | 0.17x | 0.96x |
| Net DebtTotal debt minus cash | $363M | -$404M | $860M | -$206M | $369M |
| Cash & Equiv.Liquid assets | $73M | $404M | $421M | $307M | $202M |
| Total DebtShort + long-term debt | $436M | $0 | $1.3B | $100M | $572M |
| Interest CoverageEBIT ÷ Interest expense | 5.16x | — | -0.96x | -5.51x | -9.01x |
Total Returns (Dividends Reinvested)
ADEA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ADEA five years ago would be worth $51,392 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, PTEN leads with a +111.0% total return vs VRNS's -36.7%. The 3-year compound annual growth rate (CAGR) favors ADEA at 56.9% vs IPGP's -4.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +56.3% | +35.8% | +77.9% | +25.8% | -10.5% |
| 1-Year ReturnPast 12 months | +110.8% | +75.6% | +111.0% | +53.3% | -36.7% |
| 3-Year ReturnCumulative with dividends | +286.0% | -12.7% | +17.3% | +19.7% | +23.7% |
| 5-Year ReturnCumulative with dividends | +413.9% | -48.5% | +48.7% | -20.9% | -39.9% |
| 10-Year ReturnCumulative with dividends | +298.3% | +20.2% | -22.1% | +2.5% | +317.5% |
| CAGR (3Y)Annualised 3-year return | +56.9% | -4.4% | +5.5% | +6.2% | +7.3% |
Risk & Volatility
PTEN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PTEN is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than ADEA's 1.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PTEN currently trades 90.4% from its 52-week high vs VRNS's 44.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.95x | 1.80x | 0.59x | 0.76x | 0.95x |
| 52-Week HighHighest price in past year | $34.34 | $155.82 | $12.62 | $5.27 | $63.90 |
| 52-Week LowLowest price in past year | $11.61 | $53.98 | $5.10 | $3.03 | $19.70 |
| % of 52W HighCurrent price vs 52-week peak | +79.8% | +65.2% | +90.4% | +89.3% | +44.9% |
| RSI (14)Momentum oscillator 0–100 | 52.7 | 39.7 | 55.4 | 57.4 | 66.1 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 510K | 10.6M | 343K | 2.3M |
Analyst Outlook
Evenly matched — ADEA and PTEN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ADEA as "Buy", IPGP as "Buy", PTEN as "Buy", ACTG as "Buy", VRNS as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs -3.6% for PTEN (target: $11). For income investors, PTEN offers the higher dividend yield at 2.80% vs ADEA's 0.70%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $30.00 | $151.67 | $11.00 | — | $36.00 |
| # AnalystsCovering analysts | 5 | 27 | 53 | 7 | 34 |
| Dividend YieldAnnual dividend ÷ price | +0.7% | — | +2.8% | — | — |
| Dividend StreakConsecutive years of raises | 2 | 1 | 1 | 0 | — |
| Dividend / ShareAnnual DPS | $0.19 | — | $0.32 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +1.3% | +1.6% | 0.0% | +3.4% |
ADEA leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACTG leads in 1 (Valuation Metrics). 1 tied.
ADEA vs IPGP vs PTEN vs ACTG vs VRNS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ADEA or IPGP or PTEN or ACTG or VRNS a better buy right now?
For growth investors, Acacia Research Corporation (ACTG) is the stronger pick with 133.
2% revenue growth year-over-year, versus -10. 3% for Patterson-UTI Energy, Inc. (PTEN). Acacia Research Corporation (ACTG) offers the better valuation at 21. 4x trailing P/E, making it the more compelling value choice. Analysts rate Adeia Inc. (ADEA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ADEA or IPGP or PTEN or ACTG or VRNS?
On trailing P/E, Acacia Research Corporation (ACTG) is the cheapest at 21.
4x versus IPG Photonics Corporation at 139. 2x. On forward P/E, Adeia Inc. is actually cheaper at 19. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ADEA or IPGP or PTEN or ACTG or VRNS?
Over the past 5 years, Adeia Inc.
(ADEA) delivered a total return of +413. 9%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: VRNS returned +317. 5% versus PTEN's -22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ADEA or IPGP or PTEN or ACTG or VRNS?
By beta (market sensitivity over 5 years), Patterson-UTI Energy, Inc.
(PTEN) is the lower-risk stock at 0. 59β versus Adeia Inc. 's 1. 95β — meaning ADEA is approximately 230% more volatile than PTEN relative to the S&P 500. On balance sheet safety, Acacia Research Corporation (ACTG) carries a lower debt/equity ratio of 17% versus 96% for Varonis Systems, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ADEA or IPGP or PTEN or ACTG or VRNS?
By revenue growth (latest reported year), Acacia Research Corporation (ACTG) is pulling ahead at 133.
2% versus -10. 3% for Patterson-UTI Energy, Inc. (PTEN). On earnings-per-share growth, the picture is similar: Acacia Research Corporation grew EPS 161. 1% year-over-year, compared to -31. 4% for Varonis Systems, Inc.. Over a 3-year CAGR, ACTG leads at 68. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ADEA or IPGP or PTEN or ACTG or VRNS?
Adeia Inc.
(ADEA) is the more profitable company, earning 25. 1% net margin versus -20. 7% for Varonis Systems, Inc. — meaning it keeps 25. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADEA leads at 47. 2% versus -23. 5% for VRNS. At the gross margin level — before operating expenses — ADEA leads at 87. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ADEA or IPGP or PTEN or ACTG or VRNS more undervalued right now?
On forward earnings alone, Adeia Inc.
(ADEA) trades at 19. 1x forward P/E versus 242. 2x for Varonis Systems, Inc. — 223. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.
08Which pays a better dividend — ADEA or IPGP or PTEN or ACTG or VRNS?
In this comparison, PTEN (2.
8% yield), ADEA (0. 7% yield) pay a dividend. IPGP, ACTG, VRNS do not pay a meaningful dividend and should not be held primarily for income.
09Is ADEA or IPGP or PTEN or ACTG or VRNS better for a retirement portfolio?
For long-horizon retirement investors, Patterson-UTI Energy, Inc.
(PTEN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 59), 2. 8% yield). IPG Photonics Corporation (IPGP) carries a higher beta of 1. 80 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PTEN: -22. 1%, IPGP: +20. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ADEA and IPGP and PTEN and ACTG and VRNS?
These companies operate in different sectors (ADEA (Technology) and IPGP (Technology) and PTEN (Energy) and ACTG (Industrials) and VRNS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ADEA is a small-cap high-growth stock; IPGP is a small-cap quality compounder stock; PTEN is a small-cap quality compounder stock; ACTG is a small-cap high-growth stock; VRNS is a small-cap quality compounder stock. ADEA, PTEN pay a dividend while IPGP, ACTG, VRNS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.